Non AIDS complications and treatment optimizations for HIV-1 infected Thai adult patients with and without TB or hepatitis

Front cover

Title pages

Table of contents

Chapter 1: General introduction

Chapter 2: A randomised trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

Chapter 3: Efficacy of tenofovir plus emtricitabine compared to emtricitabine in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

Chapter 4: Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand

Chapter 5: Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression

Chapter 6: Decline in serum 25-OH vitamin D levels in HIV-hepatitis B virus (HBV) co-infected patients after long term antiretroviral therapy

Chapter 7: Predictors of advanced liver fibrosis among hepatitis C (HCV)/HIV co-infected and HCV mono-infected patients from Thailand: The roles of HIV, HCV genotype and levels of vitamin D

Chapter 8: Challenges in providing treatment and care for viral hepatitis among individuals co-infected with HIV in resource-limited settings

Chapter 10: Pharmacokinetics and 48 weeks efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis co-infection receiving highly active antiretroviral therapy and rifampicin

Chapter 11: Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin treated HIV/tuberculosis co-infected patients: A pilot study

Chapter 12: Feasibility and efficacy of isoniazid prophylaxis for latent tuberculosis in HIV-infected clients patients in Thailand

Chapter 13: General discussion

Summary

Samenvatting

Summary in Thai

PhD portfolio

List of publications

Acknowledgements

Biography